Released on: April 9, 2008, 3:03 pm

Press Release Author: AnaSpec Inc.

Industry: Biotech

Press Release Summary: AnaSpec has introduced its newest MMP antibodies

Press Release Body: San Jose, CA - April 9, 2008
Continuing in its commitment to developing new MMP solutions, AnaSpec has introduced
its newest MMP antibodies - anti-MMP-8 (hinge), anti-MMP-9 (hinge), anti-MMP-11
(hinge), anti-MMP-13 (IN) and anti-MMP-28 (IN) antibodies.

Matrix metalloproteinases (MMP) belong to a family of proteolytic enzymes capable of
degrading connective tissue components, making them important in embryonic
development, apoptosis, tumor cell growth, invasion, metastasis, angiogenesis and
wound healing. Substrates for MMPs include cell adhesion molecules, growth factors,
cytokines, and proteases. Immunogens used to develop these antibodies include
synthetic peptides, recombinant and native proteins. Applications include western
blot, IHC, IP, and ELISA.

Company Info

AnaSpec, Inc. is a leading provider of integrated proteomics solutions to
pharmaceutical, biotech, and academic research institutions throughout the world.
With a vision for innovation through synergy, AnaSpec focuses on three core
technologies: peptides, detection reagents (dyes, assay kits, & antibodies), and
combinatorial chemistry.

For more information, visit www.anaspec.com



Web Site: http://www.anaspec.com

Contact Details: AnaSpec Inc.
2149 O\'Toole Ave.
San Jose, CA 95131
1-408-452-5055 (Tel)
1-408-452-5059 (Fax)
1-800-452-5530
ping@anaspec.com
www.anaspec.com